2Pappas G, Akritidis N, Bosikovski M and Tsianos E. Brocellosis [ J ]. N Engl J Med 2005,352:2325 - 2336.
3Pappas G, Bosikovski M, Akritidis N. Mastora M, Krteva L and Tsianos E. Brocellosis and the respiratory system [ J ]. Clin Infect Dis. 2003,37 (7) :95 - 99.
4Akritidis N, Tzivras M, Delladetsima I, Stefanaki S, Moutsopoulos HM, Pappas G. The liver in Brucellosis [ J]. Clin Gastroenterol Heptol 2007 May 4 [ Epub ahead of print].
5Ustun I, Ozcakar L, Arda N, Duranay M, Bayrak E, Duman K, Atabay M, Cakal BE, Altundag K, Guler S [ J]. South Med J 2005,98(12) :1216.
6Pappas G, Siozopoulou V, Akritidis N, Falagas ME. Doxycycline- rifampicin : physicians inferior choice in brucellosis or how convenience reigns over science [ J ]. J Infect 2007,54( 5 ) :459 - 462.
7Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis : a randomized clinical trial [ J ]. BMC Infect Dis 2004,4 : 18.
8Dizbay M, Kilic S, Hizel K, Arman D. Tigecycline: its potential for treatment of brucellosis [ J ]. Scand J Infect Dis 2007,39 (5) :432 - 434.
9Al-Shamahy HA,Whitty CJ,Wright SG.Risk factors for human brucellosis in Yemen:a case control study[J].Epidemiol Infect,2000,125(2):309-313.
10Zowghi E,Ebadi A,Mohseni B.Isolation of Brucella organisms from the milk of seronegative cows[J].Rev Sci Teeh,1990,9(4):1175-1178.
